Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8425472 | Stem Cell Research | 2018 | 10 Pages |
Abstract
The leucine-rich repeat kinase 2 (LRRK2) p.G2019S mutation is the most common genetic cause of Parkinson's disease (PD). An induced pluripotent stem cell (iPSC) line CSC-41 was generated from a 75-year old patient diagnosed with PD caused by a p.G2019S mutation in LRRK2. Skin fibroblasts were reprogrammed using a non-integrating Sendai virus-based technology to deliver OCT3/4, SOX2, c-MYC and KLF4 transcription factors. The generated iPSC line exhibits expression of common pluripotency markers, differentiates into the three germ layers and has a normal karyotype. The iPSC line can be used to explore the association between LRRK2 mutation and PD.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Ana Marote, Yuriy Pomeshchik, Anna Collin, Stefano Goldwurm, Nuno J. Lamas, LuÃsa Pinto, António J. Salgado, Laurent Roybon,